Cargando…

Contribution of FKBP5 Genetic Variation to Gemcitabine Treatment and Survival in Pancreatic Adenocarcinoma

PURPOSE: FKBP51, (FKBP5), is a negative regulator of Akt. Variability in FKBP5 expression level is a major factor contributing to variation in response to chemotherapeutic agents including gemcitabine, a first line treatment for pancreatic cancer. Genetic variation in FKBP5 could influence its funct...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ellsworth, Katarzyna A., Eckloff, Bruce W., Li, Liang, Moon, Irene, Fridley, Brooke L., Jenkins, Gregory D., Carlson, Erin, Brisbin, Abra, Abo, Ryan, Bamlet, William, Petersen, Gloria, Wieben, Eric D., Wang, Liewei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3731355/ https://www.ncbi.nlm.nih.gov/pubmed/23936393 http://dx.doi.org/10.1371/journal.pone.0070216

Ejemplares similares

Localization of Association Signal from Risk and Protective Variants in Sequencing Studies
por: Brisbin, Abra, et al.
Publicado: (2012)

Genetic variations associated with gemcitabine treatment outcome in pancreatic cancer
por: Li, Liang, et al.
Publicado: (2016)

Genome-wide association study for biomarker identification of Rapamycin and Everolimus using a lymphoblastoid cell line system
por: Jiang, Jing, et al.
Publicado: (2013)

FKBP5 as a Selection Biomarker for Gemcitabine and Akt Inhibitors in Treatment of Pancreatic Cancer
por: Hou, Junmei, et al.
Publicado: (2012)

Gemcitabine and Arabinosylcytosin Pharmacogenomics: Genome-Wide Association and Drug Response Biomarkers
por: Li, Liang, et al.
Publicado: (2009)

Identifying the Genetic Variation of Gene Expression Using Gene Sets: Application of Novel Gene Set eQTL Approach to PharmGKB and KEGG
por: Abo, Ryan, et al.
Publicado: (2012)

Genetic association with overall survival of taxane-treated lung cancer patients - a genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study
por: Niu, Nifang, et al.
Publicado: (2012)

Use of the gamma method for self-contained gene-set analysis of SNP data
por: Biernacka, Joanna M, et al.
Publicado: (2012)

Differential roles of ERRFI1 in EGFR and AKT pathway regulation affect cancer proliferation
por: Cairns, Junmei, et al.
Publicado: (2018)

Discovery of genetic biomarkers contributing to variation in drug response of cytidine analogues using human lymphoblastoid cell lines
por: Li, Liang, et al.
Publicado: (2014)

Conserved recurrent gene mutations correlate with pathway deregulation and clinical outcomes of lung adenocarcinoma in never-smokers
por: Sun, Zhifu, et al.
Publicado: (2014)

Erratum to: Conserved recurrent gene mutations correlate with pathway deregulation and clinical outcomes of lung adenocarcinoma in never-smokers
por: Sun, Zhifu, et al.
Publicado: (2017)

Penetrating Exploration of Prognostic Correlations of the FKBP Gene Family with Lung Adenocarcinoma
por: Wang, Chin-Chou, et al.
Publicado: (2022)

Biological Actions of the Hsp90-binding Immunophilins FKBP51 and FKBP52
por: Zgajnar, Nadia R., et al.
Publicado: (2019)

FKBP4 integrates FKBP4/Hsp90/IKK with FKBP4/Hsp70/RelA complex to promote lung adenocarcinoma progression via IKK/NF-κB signaling
por: Zong, Shuai, et al.
Publicado: (2021)

Genetic Association Studies of Copy-Number Variation: Should Assignment of Copy Number States Precede Testing?
por: Breheny, Patrick, et al.
Publicado: (2012)

FKBP51 and FKBP12.6—Novel and tight interactors of Glomulin
por: Hähle, Andreas, et al.
Publicado: (2019)

Meta-analysis of 8q24 for seven cancers reveals a locus between NOV and ENPP2 associated with cancer development
por: Brisbin, Abra G, et al.
Publicado: (2011)

Modulating FKBP5/FKBP51 and autophagy lowers HTT (huntingtin) levels
por: Bailus, Barbara J., et al.
Publicado: (2021)

A New Anti-Depressive Strategy for the Elderly: Ablation of FKBP5/FKBP51
por: O'Leary, John C., et al.
Publicado: (2011)

FKBP52 and FKBP51 differentially regulate the stability of estrogen receptor in breast cancer
por: Habara, Makoto, et al.
Publicado: (2022)

Real-world outcomes of adjuvant gemcitabine versus gemcitabine plus capecitabine for resected pancreatic ductal adenocarcinoma
por: Kang, Sora, et al.
Publicado: (2022)

The Many Faces of FKBP51
por: Hähle, Andreas, et al.
Publicado: (2019)

FKBP51 and FKBP52 regulate androgen receptor dimerization and proliferation in prostate cancer cells
por: Maeda, Keisuke, et al.
Publicado: (2021)

Effect of FKBP12-Derived Intracellular Peptides on Rapamycin-Induced FKBP–FRB Interaction and Autophagy
por: Parada, Carolina A., et al.
Publicado: (2022)

Self-Contained Gene-Set Analysis of Expression Data: An Evaluation of Existing and Novel Methods
por: Fridley, Brooke L., et al.
Publicado: (2010)

Analysis of FK506, timcodar (VX-853) and FKBP51 and FKBP52 chaperones in control of glucocorticoid receptor activity and phosphorylation
por: Hinds, Terry D, et al.
Publicado: (2014)

Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study
por: Demols, A, et al.
Publicado: (2006)

Differential conformational dynamics in the closely homologous FK506-binding domains of FKBP51 and FKBP52
por: Mustafi, Sourajit M., et al.
Publicado: (2014)

FKBP51 decreases cell proliferation and increases progestin sensitivity of human endometrial adenocarcinomas by inhibiting Akt
por: Dong, Jing, et al.
Publicado: (2017)

Building Resilience with Aerobic Exercise: Role of FKBP5
por: Sampedro-Piquero, P., et al.
Publicado: (2021)

Real‐world evidence of adjuvant gemcitabine plus capecitabine vs gemcitabine monotherapy for pancreatic ductal adenocarcinoma
por: de Jong, Evelien J. M., et al.
Publicado: (2021)

FKBP12 Activates the Cardiac Ryanodine Receptor Ca(2+)-Release Channel and Is Antagonised by FKBP12.6
por: Galfré, Elena, et al.
Publicado: (2012)

Differential Effects of Fkbp4 and Fkbp5 on Regulation of the Proopiomelanocortin Gene in Murine AtT-20 Corticotroph Cells
por: Kageyama, Kazunori, et al.
Publicado: (2021)

Subcellular Expression Patterns of FKBP Prolyl Isomerase 10 (FKBP10) in Colorectal Cancer and Its Clinical Significance
por: Fu, Yating, et al.
Publicado: (2023)

Characterization of the FKBP12-Encoding Genes in Aspergillus fumigatus
por: Falloon, Katie, et al.
Publicado: (2015)

Genetic validation of PfFKBP35 as an antimalarial drug target
por: Thommen, Basil T, et al.
Publicado: (2023)

A Pilot Study of Blood-Based Methylation Markers Associated With Pancreatic Cancer
por: Jansen, Rick J., et al.
Publicado: (2022)

ALK2 Receptor Kinase Association with FKBP12.6 Is Structurally Conserved with the ALK2-FKBP12 Complex
por: Williams, Eleanor, et al.
Publicado: (2021)

Bayesian Linkage Analysis of Categorical Traits for Arbitrary Pedigree Designs
por: Brisbin, Abra, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_10shc7jlmu9emcahd17fq3brt6